ArticleInternational journal of molecular sciences2026
Age-Related Platelet Cox-1 Upregulation in Atrial Fibrillation.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is associated with enhanced platelet activation that may contribute to the occurrence of cardiovascular events. However, the mechanism linking aging with platelet activation is not fully understood. The objective of this study is to investigate the relationship between aging, platelet Cox-1 expression, and thromboxane (Tx) B2 production in patients with atrial fibrillation. Serum Cox-1 and TxB2 were measured in 134 patients with atrial fibrillation. Correlations were assessed between age, Cox-1, and TxB2. A robust mediation analysis evaluated whether Cox-1 mediates the association between age and TxB2. In vitro experiments were performed in 20 patients to evaluate the effect of aspirin on platelet TxB2 production and to quantify platelet Cox-1 expression across age groups (i.e., < or ≥65 years). Serum Cox-1 and TxB2 progressively increased by decades of age. A positive and significant correlation was found between age and Cox-1 (R = 0.42,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.